SS-31 — Technical Research Profile

Molecular and structural context

SS-31, also known as elamipretide, is the tetrapeptide D-Arg–dimethylTyr–Lys–Phe–NH2. Its alternating aromatic and cationic character supports mitochondrial partitioning without relying on the large membrane potential required by conventional lipophilic cations.

Mechanistic research framework

Research has focused on association with cardiolipin-containing membranes, respiratory-chain organization, electron-transfer efficiency, membrane curvature, and oxidative-stress responses. Mechanistic conclusions should distinguish direct membrane effects from secondary changes in cellular redox state.

Laboratory models examine mitochondrial membrane interactions, respiratory efficiency, oxidative stress, and cellular energy resilience.

Experimental applications and endpoint selection

Endpoints may include oxygen-consumption rate, ATP-linked respiration, membrane potential, mitochondrial morphology, lipid oxidation, cardiolipin interactions, and reactive-oxygen-species measurements. Mitochondrial stress-test controls improve interpretation.

This material is intended for analytical, biochemical, receptor-pharmacology, cellular, or other controlled preclinical workflows as appropriate to the target system. Study design should define the biological matrix, exposure duration, concentration range, replicate structure, acceptance criteria, and statistical plan before data collection.

Principal areas of scientific inquiry

• Mitochondrial membrane research
• Cellular bioenergetics
• Oxidative-stress response models

Technical keywords

• Cardiolipin interaction
• Mitochondrial respiration
• Aromatic-cationic peptide
• Oxidative stress

Analytical characterization considerations

Dimethyltyrosine oxidation, terminal amidation, stereochemistry, and adsorption can influence results. LC-MS and RP-HPLC establish chemical identity, while membrane-binding and respirometry assays address mechanism and function.

Where scientifically appropriate, laboratories may use orthogonal methods such as reversed-phase HPLC for chromatographic purity, LC-MS for molecular identity, size-sensitive methods for aggregation, and a target-relevant functional assay for biological activity. Method suitability, reference standards, system suitability, and acceptance limits must be independently established; these examples are not batch-specific analytical claims.

Study design and interpretation

Use vehicle, positive, negative, and concentration-matched controls appropriate to the assay. Receptor expression, biological matrix, incubation time, adsorption, proteolysis, passage number, and species background can all change apparent potency or pathway output. Observations from in vitro or animal models should not be extrapolated to human use.

Handling and documentation

Use calibrated equipment and documented receipt, storage, preparation, aliquoting, freeze-thaw, and disposal procedures. Solvent compatibility, working concentration, stability window, container adsorption, and assay recovery must be established by the purchasing laboratory using the applicable batch documentation and institutional standard operating procedures.

Important compliance and safety remarks

• No therapeutic, diagnostic, cosmetic, or veterinary claims are made.
• Work must be performed by qualified personnel under applicable institutional and regulatory requirements.
• Use appropriate personal protective equipment and controlled laboratory procedures.

For research use only. Not for human or animal consumption.